Sunday, February 23, 2025, 11:11AM |  26°
MENU
Advertisement
Corinne Ogrodnik, CEO and co-founder of Maitri Medicinals, said because anxiety disorders are so common she is expecting to see an increase in demand once it becomes a qualifying condition on Saturday. She is standing outside her dispensary, Tuesday, July 16, 2019, in East Liberty.
3
MORE

Medical marijuana for anxiety? Some doctors question state's decision

Alexandra Wimley/Post-Gazette

Medical marijuana for anxiety? Some doctors question state's decision

It’s the most common mental illness in the United States.

And starting Saturday, those with anxiety disorders will have a new option for treatment in the state of Pennsylvania: medical marijuana.

“I do not take this decision lightly,” said state health secretary Rachel Levine, announcing the decision last week to add both anxiety and Tourette syndrome to the list of 21 existing qualifying conditions, “and do have recommendations for physicians, dispensary pharmacists and patients in terms of medical marijuana to treat these conditions.”

Advertisement

The state Medical Marijuana Advisory Board voted in February to recommend anxiety and Tourette as qualifying conditions. Tourette is a neurological disorder characterized by repetitive involuntary movements and vocalizations called tics.

Dr. Levine went on to say in a statement that marijuana should be used only in addition to existing therapies such as counseling for anxiety patients and should not be used by children and adolescents or by pregnant women.

But local doctors are cautioning that it should only be used as a last resort — if at all.

“There is really no clear evidence for the therapeutic benefits of cannabis for anxiety disorders,” said Antoine Douaihy, senior academic director of UPMC addiction medicine services and a member of the state Medical Marijuana Physician Workgroup. “For people who have an anxiety disorder there are so many good treatments — adding medical marijuana is more of a last-resort approach.”

Advertisement

P.V. Nickell, chair of the psychiatry and behavioral health institute for Allegheny Health Network, also expressed concerns. “Based on my limited knowledge, I’m not convinced it was a good idea,” he said. “It’s kind of the wild west out there because we’re not getting good data and people are doing stuff anyway.”

Dr. Levine, who was interviewed Tuesday on WESA-FM’s “The Confluence,” said she believed there is “significant evidence in the medical literature that medical marijuana can be beneficial for patients with anxiety disorders and for patients with Tourette syndrome,” but added that it is not to be used as a first-line treatment.

For Corinne Ogrodnik, CEO and co-founder of the Maitri medical marijuana dispensaries in East Liberty and Uniontown, the change is a welcome one.

Ms. Ogrodnik said that she has already heard anecdotally from patients who are being treated with medical marijuana for currently qualifying conditions that their anxiety symptoms have improved as well. Since Dr. Levine announced last week that anxiety would be approved as a qualifying condition, Ms. Ogrodnik said her dispensaries have fielded calls from several doctors checking on the procedures to get their patients approved.

“If this product can help them, we are very happy,” she said, noting that one patient with a chronic pain condition told her that she has reduced her anxiety medication since starting treatment with marijuana. “For those people who feel like this product can help them, whether their condition is severe or minor, it’s important to be able to provide them with a safe alternative.”

In Pennsylvania, patients who wish to use medical marijuana must see a physician certified by the state specifically to recommend medical marijuana. Pennsylvania law allows patients to vape medical marijuana or to ingest it in oil form, but does not permit smoking the drug or permit the sale of edibles. 

Because anxiety disorders are so common, Ms. Ogrodnik is expecting to see some increase in demand. “We expect to see a small bump,” she said. “I’m not sure if we’ll see a significant bump, it’s hard to say. That’s part of the mystery and fascination of being involved in this industry.”

Nationally, patients with anxiety are not a large proportion of those using medical marijuana. A study published in March in the journal Health Affairs analyzed data from states that publish marijuana use by condition and found that chronic pain accounts for 62.2 percent of usage, followed by muscle spasms in multiple sclerosis patients and chemotherapy-induced nausea and vomiting.

According to the website, Leafly.com, only one other state, New Jersey, has specifically approved anxiety as a qualifying condition for medical marijuana, though some states do have a catch-all provision approving marijuana as a treatment for all diseases deemed beneficial by a physician.

In Ohio, the topic has become controversial. In May, a four-member committee of the Ohio Medical Board voted to approve anxiety and autism as qualifying conditions. Last month, however, the full board decided to delay the decision after receiving a letter from physicians at Nationwide Children’s Hospital noting the lack of scientific research and citing the potential that cannabis use could worsen psychiatric disorders.

It is the potential for medical marijuana to harm patients with anxiety that concerns Dr. Nickell as well. “We don’t know if it will help or hurt,” he said. “Anxiety can be from a lot of things. It can be from too much Starbucks. It can be from medical problems like hypothyroidism. I don’t know the discipline that people would bring to the assessments, and it concerns me about people being not appropriately diagnosed, much less whether it’s an appropriate treatment.”

Dr. Douaihy declined to say what his official recommendation on the subject was as a member of the state physician workgroup, noting that he appreciated Dr. Levine’s willingness to listen and was pleased with how the state’s medical marijuana program was running generally.

But as an expert on addiction, he said he was concerned about marijuana use for people with mental illness who may already be predisposed toward addiction or substance abuse.

“There is a very strong disconnect between public perspectives and scientific evidence that does not exist and the public policies that are generated,” he said. “There’s very much a mismatch between these three pieces. You know, it could work, it could not work.”

Anya Sostek: asostek@post-gazette.com or 412-263-1308. Twitter @asostekPG.

Correction, posted July 17, 2019: Antoine Douaihy is a member of Pennsylvania's Medical Marijuana Physician Workgroup. An earlier version of this story listed him as a member of a different group that advises the state health secretary on medical marijuana.

First Published: July 17, 2019, 11:00 a.m.
Updated: July 17, 2019, 11:26 a.m.

RELATED
SHOW COMMENTS (0)  
Join the Conversation
Commenting policy | How to Report Abuse
If you would like your comment to be considered for a published letter to the editor, please send it to letters@post-gazette.com. Letters must be under 250 words and may be edited for length and clarity.
Partners
Advertisement
The University of Pittsburgh's Cathedral of Learning
1
business
Amid funding uncertainty, Pitt pauses doctoral admissions
A new report advises retirees in 2025 to aim for just 3.7% when withdrawing from savings -- down from 4%. Over a 30-year retirement, that could mean the difference between financial security or outliving your cash in your 80s or 90s, financial experts say.
2
business
How much can retirees safely withdraw from their nest eggs? Financial experts weigh in.
Pirates outfielder DJ Stewart gets congratulations from teammates after his home run against the Baltimore Orioles in the first game of the Grapefruit League season at Ed Smith Stadium in Sarasota, Fla., on Saturday, Feb. 22, 2025.
3
sports
5 takeaways from Pirates' spring training victory over Orioles
York County District Attorney Timothy J. Barker reacts during a news conference regarding the shooting at UPMC Memorial Hospital in York, Pa. on Saturday, Feb. 22, 2025.
4
news
Police officer killed, gunman dead in shooting at UPMC Memorial Hospital in York
Preston Coleman, 52, was beaten and strangled inside an Aliquippa VFW on Jan. 5, 2025, in what police described as a vicious, unprovoked attack.
5
news
Bartender working at Aliquippa VFW during beating that left man unconscious facing charges
Corinne Ogrodnik, CEO and co-founder of Maitri Medicinals, said because anxiety disorders are so common she is expecting to see an increase in demand once it becomes a qualifying condition on Saturday. She is standing outside her dispensary, Tuesday, July 16, 2019, in East Liberty.  (Alexandra Wimley/Post-Gazette)
Corinne Ogrodnik, CEO and co-founder of Maitri Medicinals, said she has heard anecdotally from patients who are being treated with medical marijuana for other qualifying conditions that their anxiety symptoms have improved. She is standing outside her dispensary, Tuesday, July 16, 2019, in East Liberty.  (Alexandra Wimley/Post-Gazette)
Corinne Ogrodnik, CEO and co-founder of Maitri Medicinals, said because anxiety disorders are so common she is expecting to see an increase in demand once it becomes a qualifying condition on Saturday. She is standing outside her dispensary, Tuesday, July 16, 2019, in East Liberty.  (Alexandra Wimley/Post-Gazette)
Alexandra Wimley/Post-Gazette
Advertisement
LATEST news
Advertisement
TOP
Email a Story